Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 0 | 15 | 260 | 260 | 16 |
| Gross Profit | N/A | 15 | 260 | 260 | 16 |
| Operating Expenses | 9,297 | 8,647 | 8,520 | 13,567 | 20,653 |
| Operating Income | -9,297 | -8,632 | -8,260 | -13,307 | -20,637 |
| Interest Expense | 235 | 9 | 8 | 159 | 1,141 |
| Other Income | -803 | 289 | 3,343 | -2,200 | 704 |
| Pre-tax Income | -10,335 | -8,352 | -4,925 | -15,666 | -21,075 |
| Net Income Continuous | -10,335 | -8,352 | -4,925 | -15,666 | -21,075 |
| Net Income | $-10,335 | $-8,352 | $-4,925 | $-15,666 | $-21,075 |
| EPS Basic Total Ops | -2,788.61 | -17,088.04 | -33,906.26 | -107,924.40 | -227,540.70 |
| EPS Basic Continuous Ops | -2,792.85 | -17,094.28 | -33,913.13 | -107,850.00 | -227,101.30 |
| EPS Diluted Total Ops | -2,788.61 | -17,088.04 | -33,906.26 | -107,924.40 | -227,540.70 |
| EPS Diluted Continuous Ops | -2,792.85 | -17,094.28 | -33,913.13 | -107,850.00 | -227,101.30 |
| EPS Diluted Before Non-Recurring Items | -5,261.32 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-9,294 | $-8,488 | $-8,074 | $-12,958 | $-19,952 |